Cargando…

MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer

Accumulating evidences have revealed that dysregulated microRNAs (miRNAs) involve in the tumorigenesis, progression and even lead to poor prognosis of various carcinomas, including breast cancer. MiRNA-106b-5p (miR-106b) and miRNA-93-5p (miR-93) levels were confirmed to be significantly upregulated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Nana, Miao, Yuan, Shan, Yujia, Liu, Bing, Li, Yang, Zhao, Lifen, Jia, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520687/ https://www.ncbi.nlm.nih.gov/pubmed/28518139 http://dx.doi.org/10.1038/cddis.2017.119

Ejemplares similares

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT
por: Zheng, Zhiming, et al.
Publicado: (2017)

Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML
por: Zhao, Lifen, et al.
Publicado: (2017)

Altered expression of serum miR‐106a, miR‐19b, miR‐17, and PTEN in patients with idiopathic membranous nephropathy
por: Wu, Lina, et al.
Publicado: (2021)

miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
por: Choi, Nahyun, et al.
Publicado: (2015)

Retraction Note: Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML
por: Zhao, Lifen, et al.
Publicado: (2020)

Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer
por: Zhang, Rupeng, et al.
Publicado: (2017)

MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
por: Zheng, Lin, et al.
Publicado: (2015)

Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer
por: Li, Yang, et al.
Publicado: (2017)

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
por: Nakka, Manjula, et al.
Publicado: (2017)

Propofol Inhibits Microglial Activation via miR-106b/Pi3k/Akt Axis
por: Liu, Jianhui, et al.
Publicado: (2021)

miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer
por: Li, Ye, et al.
Publicado: (2020)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging
por: Hackl, Matthias, et al.
Publicado: (2010)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25
por: Khuu, Cuong, et al.
Publicado: (2016)

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
por: Bayat, Parisa, et al.
Publicado: (2022)

The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors
por: Gruszka, Renata, et al.
Publicado: (2018)

miR-106b suppresses pathological retinal angiogenesis
por: Ménard, Catherine, et al.
Publicado: (2020)

[Rectacted] miR‑106b‑5p promotes cell cycle progression of malignant melanoma by targeting PTEN
por: Chen, Xu-E, et al.
Publicado: (2023)

miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness
por: Petrova, Tatiana A., et al.
Publicado: (2022)

Repression of human activation induced cytidine deaminase by miR-93 and miR-155
por: Borchert, Glen M, et al.
Publicado: (2011)

miR-93 Promotes Cell Proliferation in Gliomas through Activation of PI3K/Akt Signaling Pathway
por: Jiang, Lili, et al.
Publicado: (2015)

Oxidative stress-induced mitophagy is suppressed by the miR-106b-93-25 cluster in a protective manner
por: Zhang, Cheng, et al.
Publicado: (2021)

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
por: Huh, J H, et al.
Publicado: (2013)

MiR-17 and miR-93 Promote Tumor Progression by Targeting p21 in Patients with Chordoma
por: Dong, Wei, et al.
Publicado: (2021)

Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients
por: Barry, Simone E, et al.
Publicado: (2015)

Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
por: Ni, Qingtao, et al.
Publicado: (2018)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway
por: Shi, Dong-Min, et al.
Publicado: (2018)

MiR-21 promotes pterygium cell proliferation through the PTEN/AKT pathway
por: Li, Xia, et al.
Publicado: (2018)

miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway
por: Xu, Fen, et al.
Publicado: (2020)

Deletion of the miR‐25/93/106b cluster induces glomerular deposition of immune complexes and renal fibrosis in mice
por: Ma, Hongchuang, et al.
Publicado: (2021)

miR-382 targeting PTEN-Akt axis promotes liver regeneration
por: Bei, Yihua, et al.
Publicado: (2015)

Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer
por: Zhu, Wangyu, et al.
Publicado: (2014)

Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
por: Ni, Qingtao, et al.
Publicado: (2019)

Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

Effects of miR-21 on proliferation and apoptosis of WT cells via PTEN/Akt pathway
por: Zhang, Xiuli, et al.
Publicado: (2020)

miR-106b as an emerging therapeutic target in cancer
por: Sagar, Surendra Kumar
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l1eugssoopv8sn4816md3vmgoq